 | • レポートコード：MR2211M-3927 • 出版社/出版日：Market Monitor Global / 2022年5月 • レポート形態：英文、PDF、65ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、過食症治療のグローバル市場規模と予測を記載しています。・過食症治療のグローバル市場：売上、2017年-2022年、2023年-2028年 ・過食症治療のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 過食症治療のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「医薬品」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 過食症治療のグローバル主要企業は、Chronos Therapeutics、 Shire US Inc. (part of Takeda Pharmaceutical Company)、 Eli Lilly and Company、 Sunovion Pharmaceuticals Inc、 Promises Behavioral Health、 Pyramid Healthcare (Tapestry Eating Disorder Services)、 Timberline Knolls、 Rosewood Centers for Eating Disorders、 Walden Behavioral Care、 Roche、 Opiant Pharmaceuticals、 Heptares、 Novo Nordiskなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、過食症治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の過食症治療市場：タイプ別、2017年-2022年、2023年-2028年 世界の過食症治療市場：タイプ別市場シェア、2021年 ・医薬品、サービス 世界の過食症治療市場：用途別、2017年-2022年、2023年-2028年 世界の過食症治療市場：用途別市場シェア、2021年 ・病院、クリニック 世界の過食症治療市場：地域・国別、2017年-2022年、2023年-2028年 世界の過食症治療市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における過食症治療のグローバル売上、2017年-2022年 ・主要企業における過食症治療のグローバル売上シェア、2021年 ・主要企業における過食症治療のグローバル販売量、2017年-2022年 ・主要企業における過食症治療のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Chronos Therapeutics、 Shire US Inc. (part of Takeda Pharmaceutical Company)、 Eli Lilly and Company、 Sunovion Pharmaceuticals Inc、 Promises Behavioral Health、 Pyramid Healthcare (Tapestry Eating Disorder Services)、 Timberline Knolls、 Rosewood Centers for Eating Disorders、 Walden Behavioral Care、 Roche、 Opiant Pharmaceuticals、 Heptares、 Novo Nordisk ************************************************************* ・調査・分析レポートの概要 過食症治療市場の定義 市場セグメント 世界の過食症治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の過食症治療市場規模 世界の過食症治療市場規模：2021年 VS 2028年 世界の過食症治療市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの過食症治療の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の過食症治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：医薬品、サービス 過食症治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック 過食症治療の用途別グローバル売上・予測 ・地域別市場分析 地域別過食症治療市場規模 2021年と2028年 地域別過食症治療売上・予測 北米市場 - アメリカの過食症治療市場規模2017年-2028年 - カナダの過食症治療市場規模2017年-2028年 - メキシコの過食症治療市場規模2017年-2028年 ヨーロッパ市場 - ドイツの過食症治療市場規模2017年-2028年 - フランスの過食症治療市場規模2017年-2028年 - イギリスの過食症治療市場規模2017年-2028年 - イタリアの過食症治療市場規模2017年-2028年 - ロシアの過食症治療市場規模2017年-2028年 アジア市場 - 中国の過食症治療市場規模2017年-2028年 - 日本の過食症治療市場規模2017年-2028年 - 韓国の過食症治療市場規模2017年-2028年 - 東南アジアの過食症治療市場規模2017年-2028年 - インドの過食症治療市場規模2017年-2028年 南米市場 - ブラジルの過食症治療市場規模2017年-2028年 - アルゼンチンの過食症治療市場規模2017年-2028年 中東・アフリカ市場 - トルコの過食症治療市場規模2017年-2028年 - イスラエルの過食症治療市場規模2017年-2028年 - サウジアラビアの過食症治療市場規模2017年-2028年 - UAEの過食症治療市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Chronos Therapeutics、 Shire US Inc. (part of Takeda Pharmaceutical Company)、 Eli Lilly and Company、 Sunovion Pharmaceuticals Inc、 Promises Behavioral Health、 Pyramid Healthcare (Tapestry Eating Disorder Services)、 Timberline Knolls、 Rosewood Centers for Eating Disorders、 Walden Behavioral Care、 Roche、 Opiant Pharmaceuticals、 Heptares、 Novo Nordisk ... |
This report contains market size and forecasts of Binge Eating Disorder Treatment in Global, including the following market information:
Global Binge Eating Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Binge Eating Disorder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Binge Eating Disorder Treatment include Chronos Therapeutics, Shire US Inc. (part of Takeda Pharmaceutical Company), Eli Lilly and Company, Sunovion Pharmaceuticals Inc, Promises Behavioral Health, Pyramid Healthcare (Tapestry Eating Disorder Services), Timberline Knolls, Rosewood Centers for Eating Disorders and Walden Behavioral Care, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Binge Eating Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Binge Eating Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, by Type, 2021 (%)
Medication
Services
Global Binge Eating Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Binge Eating Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Binge Eating Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Binge Eating Disorder Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chronos Therapeutics
Shire US Inc. (part of Takeda Pharmaceutical Company)
Eli Lilly and Company
Sunovion Pharmaceuticals Inc
Promises Behavioral Health
Pyramid Healthcare (Tapestry Eating Disorder Services)
Timberline Knolls
Rosewood Centers for Eating Disorders
Walden Behavioral Care
Roche
Opiant Pharmaceuticals
Heptares
Novo Nordisk
Omeros Corp
1 Introduction to Research & Analysis Reports
1.1 Binge Eating Disorder Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Binge Eating Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Binge Eating Disorder Treatment Overall Market Size
2.1 Global Binge Eating Disorder Treatment Market Size: 2021 VS 2028
2.2 Global Binge Eating Disorder Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Binge Eating Disorder Treatment Players in Global Market
3.2 Top Global Binge Eating Disorder Treatment Companies Ranked by Revenue
3.3 Global Binge Eating Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Binge Eating Disorder Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Binge Eating Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Binge Eating Disorder Treatment Players in Global Market
3.6.1 List of Global Tier 1 Binge Eating Disorder Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Binge Eating Disorder Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Binge Eating Disorder Treatment Market Size Markets, 2021 & 2028
4.1.2 Medication
4.1.3 Services
4.2 By Type – Global Binge Eating Disorder Treatment Revenue & Forecasts
4.2.1 By Type – Global Binge Eating Disorder Treatment Revenue, 2017-2022
4.2.2 By Type – Global Binge Eating Disorder Treatment Revenue, 2023-2028
4.2.3 By Type – Global Binge Eating Disorder Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Binge Eating Disorder Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application – Global Binge Eating Disorder Treatment Revenue & Forecasts
5.2.1 By Application – Global Binge Eating Disorder Treatment Revenue, 2017-2022
5.2.2 By Application – Global Binge Eating Disorder Treatment Revenue, 2023-2028
5.2.3 By Application – Global Binge Eating Disorder Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Binge Eating Disorder Treatment Market Size, 2021 & 2028
6.2 By Region – Global Binge Eating Disorder Treatment Revenue & Forecasts
6.2.1 By Region – Global Binge Eating Disorder Treatment Revenue, 2017-2022
6.2.2 By Region – Global Binge Eating Disorder Treatment Revenue, 2023-2028
6.2.3 By Region – Global Binge Eating Disorder Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Binge Eating Disorder Treatment Revenue, 2017-2028
6.3.2 US Binge Eating Disorder Treatment Market Size, 2017-2028
6.3.3 Canada Binge Eating Disorder Treatment Market Size, 2017-2028
6.3.4 Mexico Binge Eating Disorder Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Binge Eating Disorder Treatment Revenue, 2017-2028
6.4.2 Germany Binge Eating Disorder Treatment Market Size, 2017-2028
6.4.3 France Binge Eating Disorder Treatment Market Size, 2017-2028
6.4.4 U.K. Binge Eating Disorder Treatment Market Size, 2017-2028
6.4.5 Italy Binge Eating Disorder Treatment Market Size, 2017-2028
6.4.6 Russia Binge Eating Disorder Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Binge Eating Disorder Treatment Market Size, 2017-2028
6.4.8 Benelux Binge Eating Disorder Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Binge Eating Disorder Treatment Revenue, 2017-2028
6.5.2 China Binge Eating Disorder Treatment Market Size, 2017-2028
6.5.3 Japan Binge Eating Disorder Treatment Market Size, 2017-2028
6.5.4 South Korea Binge Eating Disorder Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Binge Eating Disorder Treatment Market Size, 2017-2028
6.5.6 India Binge Eating Disorder Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Binge Eating Disorder Treatment Revenue, 2017-2028
6.6.2 Brazil Binge Eating Disorder Treatment Market Size, 2017-2028
6.6.3 Argentina Binge Eating Disorder Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Binge Eating Disorder Treatment Revenue, 2017-2028
6.7.2 Turkey Binge Eating Disorder Treatment Market Size, 2017-2028
6.7.3 Israel Binge Eating Disorder Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Binge Eating Disorder Treatment Market Size, 2017-2028
6.7.5 UAE Binge Eating Disorder Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Chronos Therapeutics
7.1.1 Chronos Therapeutics Corporate Summary
7.1.2 Chronos Therapeutics Business Overview
7.1.3 Chronos Therapeutics Binge Eating Disorder Treatment Major Product Offerings
7.1.4 Chronos Therapeutics Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.1.5 Chronos Therapeutics Key News
7.2 Shire US Inc. (part of Takeda Pharmaceutical Company)
7.2.1 Shire US Inc. (part of Takeda Pharmaceutical Company) Corporate Summary
7.2.2 Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
7.2.3 Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Major Product Offerings
7.2.4 Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.2.5 Shire US Inc. (part of Takeda Pharmaceutical Company) Key News
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Corporate Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Binge Eating Disorder Treatment Major Product Offerings
7.3.4 Eli Lilly and Company Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly and Company Key News
7.4 Sunovion Pharmaceuticals Inc
7.4.1 Sunovion Pharmaceuticals Inc Corporate Summary
7.4.2 Sunovion Pharmaceuticals Inc Business Overview
7.4.3 Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Major Product Offerings
7.4.4 Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.4.5 Sunovion Pharmaceuticals Inc Key News
7.5 Promises Behavioral Health
7.5.1 Promises Behavioral Health Corporate Summary
7.5.2 Promises Behavioral Health Business Overview
7.5.3 Promises Behavioral Health Binge Eating Disorder Treatment Major Product Offerings
7.5.4 Promises Behavioral Health Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.5.5 Promises Behavioral Health Key News
7.6 Pyramid Healthcare (Tapestry Eating Disorder Services)
7.6.1 Pyramid Healthcare (Tapestry Eating Disorder Services) Corporate Summary
7.6.2 Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
7.6.3 Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Major Product Offerings
7.6.4 Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.6.5 Pyramid Healthcare (Tapestry Eating Disorder Services) Key News
7.7 Timberline Knolls
7.7.1 Timberline Knolls Corporate Summary
7.7.2 Timberline Knolls Business Overview
7.7.3 Timberline Knolls Binge Eating Disorder Treatment Major Product Offerings
7.7.4 Timberline Knolls Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.7.5 Timberline Knolls Key News
7.8 Rosewood Centers for Eating Disorders
7.8.1 Rosewood Centers for Eating Disorders Corporate Summary
7.8.2 Rosewood Centers for Eating Disorders Business Overview
7.8.3 Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Major Product Offerings
7.8.4 Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.8.5 Rosewood Centers for Eating Disorders Key News
7.9 Walden Behavioral Care
7.9.1 Walden Behavioral Care Corporate Summary
7.9.2 Walden Behavioral Care Business Overview
7.9.3 Walden Behavioral Care Binge Eating Disorder Treatment Major Product Offerings
7.9.4 Walden Behavioral Care Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.9.5 Walden Behavioral Care Key News
7.10 Roche
7.10.1 Roche Corporate Summary
7.10.2 Roche Business Overview
7.10.3 Roche Binge Eating Disorder Treatment Major Product Offerings
7.10.4 Roche Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.10.5 Roche Key News
7.11 Opiant Pharmaceuticals
7.11.1 Opiant Pharmaceuticals Corporate Summary
7.11.2 Opiant Pharmaceuticals Business Overview
7.11.3 Opiant Pharmaceuticals Binge Eating Disorder Treatment Major Product Offerings
7.11.4 Opiant Pharmaceuticals Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.11.5 Opiant Pharmaceuticals Key News
7.12 Heptares
7.12.1 Heptares Corporate Summary
7.12.2 Heptares Business Overview
7.12.3 Heptares Binge Eating Disorder Treatment Major Product Offerings
7.12.4 Heptares Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.12.5 Heptares Key News
7.13 Novo Nordisk
7.13.1 Novo Nordisk Corporate Summary
7.13.2 Novo Nordisk Business Overview
7.13.3 Novo Nordisk Binge Eating Disorder Treatment Major Product Offerings
7.13.4 Novo Nordisk Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.13.5 Novo Nordisk Key News
7.14 Omeros Corp
7.14.1 Omeros Corp Corporate Summary
7.14.2 Omeros Corp Business Overview
7.14.3 Omeros Corp Binge Eating Disorder Treatment Major Product Offerings
7.14.4 Omeros Corp Binge Eating Disorder Treatment Revenue in Global Market (2017-2022)
7.14.5 Omeros Corp Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer